Retail trade group forecasts holiday sales rising 3.6% to 5.2%, ‘strong finish’ to 2020 in spite of pandemic
Retailers could end up having a strong finish to 2020, despite all of the challenges that the coronavirus pandemic has dealt the industry, according to a new forecast. The National Retail Federation said Monday it
Oxford-AstraZeneca Covid vaccine shows an average 70% effectiveness in preventing the virus
British pharmaceutical giant AstraZeneca said Monday an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting against the virus. It comes after a string of encouraging vaccine results in
October existing home sales see ‘spectacular’ 26.6% annual gain even with short supply and surging prices
Sales of existing homes in October soared well past expectations, rising 4.3% compared with September and 26.6% annually to a seasonally adjusted annualized rate of 6.85 million units, according to the National Association of Realtors.
Homebuilder confidence in November shatters record high, as buyers keep fleeing for the suburbs
The nation’s homebuilders have never been this happy. In November, builder confidence in the construction market for single-family homes soared to its third record high in as many months. Overall builder sentiment hit 90 on
Why Moderna’s Vaccine Win Is a Giant Leap Against Pandemics
By Max Nisen (Bloomberg Opinion) -- The world now seems likely to have at least two effective vaccines against Covid-19 with Monday's announcement of positive early data from Moderna Inc.’s 30,000-person clinical trial. The result comes a
We can stop COVID-19: Moderna vaccine success gives world more hope
(Reuters) - Moderna Inc’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far
Here’s how Goldman Sachs sees the vaccine getting delivered to Americans next year
The approval of a Covid-19 vaccine by the end of the year should lead to much of the United States being vaccinated during the first half of 2021, according to Goldman Sachs. On Thursday, the
‘Enterprise software is recession proof,’ according to a new report that tracked how the pandemic affected 400 firms
By Rosalie ChanNovember 12, 2020 Cloud-based enterprise software companies seem recession-proof, according to a new report from OpenView Venture Partners with data from over 1,200 enterprise cloud software firms between 2018 and 2020, with 400
‘We’re not going back to the same economy’: The rise of technology poses risks to low-paid service workers amid the ongoing recovery, Fed Chair Powell says
By Ben WinckNovember 12, 2020 The US economy won't return to the exact same state it was in before the pandemic, Federal Reserve Chair Jerome Powell said Thursday. The health crisis is accelerating digitization throughout
Goldman sees the S&P 500 rallying to 4,300 by end of 2021 on vaccine, divided government
Goldman Sachs is out Wednesday morning with a big call for clients. The firm has turned more bullish about the stock market on the back of the promising vaccine news and a divided U.S. government. Goldman